Our Culture

What you believe and what you value as an organization matters. Discover the DNA of our firm.

Our People

Get to know our teams and the stories of select staff members who share why they choose to work at Sands Capital.

Room with stairs

Recognized as Greenwich Quality Leader

Sands Capital is one of just four investment managers recognized this year for the service it delivers to institutional clients.

Careers

At Sands Capital, we strive to hire exceptional talent who will live our values and support our efforts to deliver on our mission.

Changing market and geopolitical environments are part of the equation for long-term investors.  As active investors, we are prepared to manage through trying times.

Papercup’s proprietary AI dubbing solutions provide high-quality, inexpensive voiceover and video localization.

Fostering Long-term Thinking

Executive Managing Director and Sr. Portfolio Manager Brian Christiansen discusses the importance of candor and collaboration in a culture that promotes long-term thinking.

Transparent Work Cultures and Inclusive Opportunities

Recruit Holdings is transforming the world of work through wage transparency and providing life-changing opportunities for immigrants and refugees.

Philosophy & Approach

Our philosophy is rooted in the belief that, over time, stock prices will reflect the earnings power and growth of the underlying businesses.

Stewardship

Our second annual stewardship report reflects our commitment to provide clients and other key stakeholders with transparency into our initiatives, actions, and the progress we made in 2022.

Public Equity

Our newest strategy takes an unconstrained approach to seeking the best growth businesses outside of the U.S.

Venture & Growth Equity

Our life sciences strategy looks to invest in promising life sciences companies that we believe are at the heart of a technological and scientific revolution in healthcare.

FEATURING:

Jenny Goldsmith, Sr. Research Analyst

Episode 2: Dexcom

Episode 2: Dexcom
August 29, 2023

In a world where more than 500M people battle diabetes, Dexcom stands out. This trailblazer in continuous glucose monitoring is on track for substantial growth amid evolving diabetes detection and treatment. In this episode, Sr. Research Analyst Jenny Goldsmith details how Dexcom’s state-of-the-art software and predictive algorithms are revolutionizing care and why she believes Dexcom’s distinctive edge translates into investment opportunities.

SHOW NOTES
TRANSCRIPT

Questions, Comments,

Podcast Ideas?

Questions, Comments, Podcast Ideas?

Disclosures:

The featured podcast portfolio companies represent a subset of Sands Capital holdings that illustrate the types of businesses in which we typically invest. The series uses rotation whereby companies are selected to highlight different sectors and geographies. 

The views expressed are the opinion of Sands Capital and are not intended as a forecast, a guarantee of future results, investment recommendations, or an offer to buy or sell any securities. The views expressed were current as of the date indicated and are subject to change. This material may contain forward-looking statements, which are subject to uncertainty and contingencies outside of Sands Capital’s control. Readers should not place undue reliance upon these forward-looking statements. There is no guarantee that Sands Capital will meet its stated goals. Past performance is not indicative of future results. A company’s fundamentals or earnings growth is no guarantee that its share price will increase. Forward earnings projections are not predictors of stock price or investment performance, and do not represent past performance. References to companies provided for illustrative purposes only. The portfolio companies identified do not represent all of the securities purchased or recommended for advisory clients. There is no assurance that any securities discussed will remain in the portfolio or that securities sold have not been repurchased. You should not assume that any investment is or will be profitable. GIPS® Reports found here.

This communication is for informational purposes only and does not constitute an offer, invitation, or recommendation to buy, sell, subscribe for, or issue any securities. The material is based on information that we consider correct, and any estimates, opinions, conclusions, or recommendations contained in this communication are reasonably held or made at the time of compilation. However, no warranty is made as to the accuracy or reliability of any estimates, opinions, conclusions, or recommendations. It should not be construed as investment, legal, or tax advice and may not be reproduced or distributed to any person.

In the United Kingdom, this communication is issued by Sands Capital Advisors – UK Ltd (“Sands UK”) and approved by Robert Quinn Advisory LLP, which is authorised and regulated by the UK Financial Conduct Authority (“FCA”). Sands UK is an Appointed Representative of Robert Quinn Advisory LLP.

This material constitutes a financial promotion for the purposes of the Financial Services and Markets Act 2000 (the “Act”) and the handbook of rules and guidance issued from time to time by the FCA (the “FCA Rules”). This material is for information purposes only and does not constitute an offer to subscribe for or purchase of any financial instrument. Sands UK neither provides investment advice to, nor receives and transmits orders from, persons to whom this material is communicated, nor does it carry on any other activities with or for such persons that constitute “MiFID or equivalent third country business” for the purposes of the FCA Rules. All information provided is not warranted as to completeness or accuracy and is subject to change without notice. This communication and any investment or service to which this material may relate is exclusively intended for persons who are Professional Clients or Eligible Counterparties for the purposes of the FCA Rules and other persons should not act or rely on it. This communication is not intended for use by any person or entity in any jurisdiction or country where such distribution or use would be contrary to local law or regulation.